Imaging Core
成像核心
基本信息
- 批准号:10647887
- 负责人:
- 金额:$ 31.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmyloidBehavioralBindingBiological MarkersBrainBrain imagingCaliberCategoriesCerebrospinal FluidClassificationClinicalClinical ResearchCollaborationsConsultConsultationsDataDatabasesDiagnosisDiagnosticDisciplineDiscipline of Nuclear MedicineEducational workshopEligibility DeterminationEnrollmentEnsureFunctional ImagingFunctional Magnetic Resonance ImagingGenerationsGeneticGoalsHippocampusHuman ResourcesImageImage AnalysisImmunohistochemistryInfrastructureLigandsLinkMagnetic Resonance ImagingMeasuresMentorsModelingNational Institute on Alcohol Abuse and AlcoholismNerve DegenerationNeuritesNeurodegenerative DisordersNeuropsychologyNuclear RadiologyParticipantPathogenesisPersonsPlasmaPositron-Emission TomographyProcessProteinsProteomicsRadiochemistryRadiology SpecialtyReadingResearchResearch PersonnelResolutionRestScanningSchoolsSourceTestingThickTrainingTreatment EfficacyWorkaccurate diagnosisclinical phenotypecraniumdata managementdemographicsdiagnostic accuracyflexibilityglial activationgray matterimprovedin vivoinnovationmolecular imagingneuropathologynovelpre-clinicalskillsstatisticsstructural imagingtau Proteinstooltraining opportunitywillingnessβ-amyloid burden
项目摘要
1. SUMMARY (Imaging Core)
The overall goals of the Imaging Core are to obtain amyloid PET and high caliber MRI data to characterize
Stanford ADRC participants along the AD and PD spectrums; to make these data available to a wide range of
investigators at Stanford; and to provide training on the acquisition, interpretation, and analysis of imaging data
relevant to neurodegenerative disease. The Imaging Core, capitalizing on Stanford's strength in brain imaging
and radiochemistry, will focus on incorporation of amyloid PET imaging in conjunction with structural and
functional MRI, and enable innovation for the exploration of novel PET targets. Dr. Greicius, the Core Director,
has helped advance the application of functional connectivity measures to the study of AD. Dr. Mormino, the
co-Director of the Imaging Core, has made contributions to characterizing the preclinical stage of AD using
amyloid and tau PET. A second major focus of the Imaging Core will be to make the acquired data available to
and readily used by researchers across disciplines and schools at Stanford. The Imaging Core will use the
RedTree infrastructure to provide researchers with summary imaging data for PET (global and regional
amyloid and tau PET values), structural measures (regional gray matter volume and thickness values), and
resting state functional measures (network connectivity). The imaging data will be linked to subjects' ancillary
data (including neuropsychological measures, spinal fluid proteins, plasma proteomics, etc.). This will allow the
widest possible set of Stanford investigators, with or without imaging expertise, to test hypotheses using the
ADRC data. The availability of amyloid PET and MRI data on the majority of clinical core participants will
greatly enhance diagnostic accuracy which will fundamentally strengthen any clinical research undertaken at
the Stanford ADRC. These imaging data, in conjunction with biofluid data from the Biomarker Core, will also
enable classification according to the recent research framework of AD so that Stanford ADRC data can be
more readily harmonized with data from other centers.
1.摘要(成像核心)
成像核心的总体目标是获得淀粉样蛋白PET和高口径核磁共振数据来表征
斯坦福大学ADRC参与者的AD和PD光谱;使这些数据适用于广泛的
斯坦福大学的研究人员;并提供成像数据的获取、解释和分析方面的培训
与神经退行性疾病有关。影像核心--充分利用斯坦福在脑成像领域的优势
和放射化学,将专注于将淀粉样蛋白PET成像与结构和
功能磁共振成像,并使探索新的PET靶点的创新成为可能。格雷修斯博士,核心主任,
促进了功能连接措施在AD研究中的应用。莫米诺医生,
影像核心联席主任,为确定AD的临床前阶段做出了贡献
淀粉样蛋白和tau PET。成像核心的第二个主要关注点将是使获取的数据可供
很容易被斯坦福大学各学科和学校的研究人员使用。成像核心将使用
RedTree基础架构可为研究人员提供PET(全球和区域)的汇总成像数据
淀粉样蛋白和tau PET值)、结构测量(区域灰质体积和厚度值)以及
休眠状态功能措施(网络连接)。成像数据将被链接到受试者的辅助
数据(包括神经心理测量、脊髓液蛋白、血浆蛋白质组学等)。这将允许
尽可能广泛的斯坦福大学调查人员,有或没有成像专业知识,以使用
ADRC数据。大多数临床核心参与者的淀粉样蛋白PET和MRI数据的可用性将
大大提高了诊断的准确性,这将从根本上加强在
斯坦福大学发展研究中心。这些成像数据与来自Biomarker Core的生物流体数据一起,还将
根据AD的最新研究框架启用分类,以便斯坦福ADRC数据可以
更容易与来自其他中心的数据协调一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH MORMINO其他文献
ELIZABETH MORMINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH MORMINO', 18)}}的其他基金
Hippocampal-dependent memory decline in aging and early Alzheimer's disease
衰老和早期阿尔茨海默病中海马依赖性记忆衰退
- 批准号:
10554313 - 财政年份:2022
- 资助金额:
$ 31.39万 - 项目类别:
Hippocampal-dependent memory decline in aging and early Alzheimer's disease
衰老和早期阿尔茨海默病中海马依赖性记忆衰退
- 批准号:
10390256 - 财政年份:2022
- 资助金额:
$ 31.39万 - 项目类别:
The impact of early medial temporal lobe Tau in human cognitive aging
早期内侧颞叶Tau蛋白对人类认知衰老的影响
- 批准号:
9507631 - 财政年份:2018
- 资助金额:
$ 31.39万 - 项目类别:
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD
遗传风险因素对临床前 AD 生物标志物和认知能力下降的影响
- 批准号:
9890985 - 财政年份:2017
- 资助金额:
$ 31.39万 - 项目类别:
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD
遗传风险因素对临床前 AD 生物标志物和认知能力下降的影响
- 批准号:
9012507 - 财政年份:2016
- 资助金额:
$ 31.39万 - 项目类别:
Deficits in top-down processes during episodic memory in aging and preclinical AD
衰老和临床前 AD 情景记忆过程中自上而下过程的缺陷
- 批准号:
8580524 - 财政年份:2013
- 资助金额:
$ 31.39万 - 项目类别:
Deficits in top-down processes during episodic memory in aging and preclinical AD
衰老和临床前 AD 情景记忆过程中自上而下过程的缺陷
- 批准号:
8455762 - 财政年份:2013
- 资助金额:
$ 31.39万 - 项目类别:
Relating amyloid pathology to cognition and brain changes in normal elderly indiv
淀粉样蛋白病理学与正常老年人认知和大脑变化的关系
- 批准号:
7546341 - 财政年份:2008
- 资助金额:
$ 31.39万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
A Possible Association Between Insulin and Alzheimer?s Disease: Examining the Consequences of Altered Insulin Signalling on the Expression of Human Amyloid-Beta in Caenorhabditis elegans
胰岛素与阿尔茨海默氏病之间的可能关联:检查胰岛素信号改变对秀丽隐杆线虫中人类β淀粉样蛋白表达的影响
- 批准号:
428670 - 财政年份:2019
- 资助金额:
$ 31.39万 - 项目类别:
Studentship Programs
Nitration of Amyloid beta Alzheimer 's disease
β 淀粉样蛋白的硝化 阿尔茨海默病
- 批准号:
316914751 - 财政年份:2016
- 资助金额:
$ 31.39万 - 项目类别:
Research Grants
Effects of Latrepirdine on beta amyloid clearance, aggregation and neurodegeneration in Alzheimer�s disease
拉曲吡啶对阿尔茨海默病β淀粉样蛋白清除、聚集和神经变性的影响
- 批准号:
nhmrc : 1009295 - 财政年份:2011
- 资助金额:
$ 31.39万 - 项目类别:
NHMRC Project Grants
An investigation of the role of brain amyloid in cognition, brain atrophy and Alzheimer s disease in Down s syndrome
脑淀粉样蛋白在唐氏综合症认知、脑萎缩和阿尔茨海默病中作用的研究
- 批准号:
G1002252/1 - 财政年份:2011
- 资助金额:
$ 31.39万 - 项目类别:
Research Grant
DECREASED CLEARANCE OF CNS AMYLOID-? IN ALZHEIMER?S DISEASE
中枢神经系统淀粉样蛋白清除率降低?
- 批准号:
8361468 - 财政年份:2011
- 资助金额:
$ 31.39万 - 项目类别:
Studies of an early stage amyloid formation for Parkinson`s Disease casual protein.
帕金森病休闲蛋白的早期淀粉样蛋白形成的研究。
- 批准号:
20550083 - 财政年份:2008
- 资助金额:
$ 31.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chemical crosslinking of helical form of amyloid-beta for the study of Alzheimer`s disease
β-淀粉样蛋白螺旋形式的化学交联用于阿尔茨海默氏病的研究
- 批准号:
318045-2005 - 财政年份:2005
- 资助金额:
$ 31.39万 - 项目类别:
Postgraduate Scholarships - Master's
In vivo imaging of beta-amyloid plaques in Alzheimer´s disease via positron emission tomography (PET)
通过正电子发射断层扫描 (PET) 对阿尔茨海默病中的 β-淀粉样斑块进行体内成像
- 批准号:
5405697 - 财政年份:2003
- 资助金额:
$ 31.39万 - 项目类别:
Research Grants
Functional studies on a neuroprotective activity of the amyloid precursor protein of Alzheimer s disease.
阿尔茨海默病淀粉样前体蛋白的神经保护活性的功能研究。
- 批准号:
nhmrc : 145761 - 财政年份:2001
- 资助金额:
$ 31.39万 - 项目类别:
NHMRC Project Grants
The neuroanatomy of Amyloid ß-Protein desposition in Alzheimer´s disease
阿尔茨海默病中淀粉样蛋白沉积的神经解剖学
- 批准号:
5326596 - 财政年份:2001
- 资助金额:
$ 31.39万 - 项目类别:
Research Grants